Company intelligence / Profile preview

Paul Capital

San Francisco, California, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Paul Capital managed over $7 billion through private equity, royalty financing, and fund-of-funds platforms; its healthcare division invested over $1 billion in commercial stage pharmaceutical, biotechnology, and medical device products, notably providing risk capital for late-stage clinical development and commercialization

Industry: Investors

Partnerships

Major global pharmaceutical companies (financed Phase III clinical trials and label expansion deals, specific names undisclosed; one example is UCB)

Beyond the preview

Go deeper on Paul Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paul Capital.

Explore the full profile